D. Gottlieb

发表

Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state

M. Schwartz, Noam Stern-Ginossar, A. Nachshon, 2020, eLife.

Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection

F. Luciani, H. McGuire, Mandeep Singh, 2020, Clinical & translational immunology.

Development of CAR T-cell lymphoma in two of ten patients effectively treated with piggyBac modified CD19 CAR T-cells.

B. Gloss, H. McGuire, S. Avdic, 2021, Blood.

BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses

P. O’Connell, E. Blyth, D. Gottlieb, 2011, Transplantation.

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

S. Fleming, K. Nicholls, J. Sasadeusz, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Manufacturing of human placenta‐derived mesenchymal stem cells for clinical trials

N. Ilić, K. Atkinson, K. Bradstock, 2009, British journal of haematology.

Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2015, Cytotherapy.

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions

M. Legiewicz, J. Tite, K. Gowrishankar, 2020, Molecular therapy. Methods & clinical development.

Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma

Seung Tae Lee, A. Rapoport, S. Dahiya, 2020, British journal of haematology.

BinomiRare: A carriers-only test for association of rare genetic variants with a binary outcome for mixed models and any case-control proportion

Benjamin D. Heavner, Sina A. Gharib, A. Reiner, 2021, medRxiv.

Adoptive T-cell therapy for fungal infections in haematology patients

D. Gottlieb, S. Deo, Shivashni S Deo, 2015, Clinical & translational immunology.

Bilateral leukemic orbital infiltration presenting as proptosis and narrow-angle glaucoma.

P. Healey, A. Maloof, D. Gottlieb, 2004, Ophthalmic plastic and reconstructive surgery.

Anncaliia algerae Microsporidial Myositis, New South Wales, Australia

D. Stark, Min-Xia Wang, C. Keighley, 2018, Emerging infectious diseases.

Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders

J. Szer, A. Roberts, K. Bradstock, 2006, Bone Marrow Transplantation.

Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity.

C. Turtle, A. Hansen, D. Gottlieb, 2009, Cytotherapy.

Optimizing Bioreactor Productivity for Therapeutic Immune Cells

A. Foster, K. Bradstock, Geoffrey W. Barton, 2005 .

The utility of strain imaging in the cardiac surveillance of bone marrow transplant patients

L. Thomas, James J. H. Chong, D. Gottlieb, 2021, Heart.

Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation

H. Heslop, A. Hoffbrand, M. Brenner, 1991, British journal of haematology.

Unusual reaction to Rituximab with intra-vascular hemolysis, rhabdomyolysis, renal failure and bone marrow necrosis.

M. Marangolo, E. Durrant, D. Gottlieb, 2006, Leukemia & lymphoma.

Hematopoietic stem cell transplant recipients surviving at least 2 years from transplant have survival rates approaching population levels in the modern era of transplantation.

I. Kerridge, J. Szer, D. Ma, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)

I. Kerridge, N. Gilroy, J. Moore, 2016, Cancer medicine.

The neurotoxicity of high‐dose cytosine arabinoside is age‐related

K. Bradstock, P. Castaldi, D. Gottlieb, 1987, Cancer.

Characterizing piggyBat—a transposase for genetic modification of T cells

B. Gloss, A. Dolnikov, K. Gowrishankar, 2022, Molecular therapy. Methods & clinical development.

Phase 1 study of selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.

R. Elstrom, W. Novotny, P. Marlton, 2019, Blood.

CALCIUM OXALATE CRYSTALLIZATION IN UNDILUTED URINE OF HEALTHY MALES: IN VITRO AND IN VIVO EFFECTS OF VARIOUS CITRATE COMPOUNDS

J. Fan, U. Herrmann, D. Gottlieb, 1999 .

Mobilisation strategies for normal and malignant cells

J. Rasko, S. Nilsson, I. Lewis, 2011, Pathology.

Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors

I. Kerridge, N. Gilroy, J. Moore, 2021, Journal of psychosocial oncology.

Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study.

I. Kerridge, N. Gilroy, J. Moore, 2020, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

A survey of infectious diseases and vaccination uptake in long‐term hematopoietic stem cell transplant survivors in Australia

I. Kerridge, N. Gilroy, J. Moore, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia

I. Kerridge, N. Gilroy, J. Moore, 2018, Bone Marrow Transplantation.

Oral health and dental morbidity in long‐term allogeneic blood and marrow transplant survivors in Australia

I. Kerridge, N. Gilroy, J. Moore, 2018, Australian dental journal.

The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, Bone Marrow Transplantation.

CD44 and adhesion of normal and leukemic CD34+ cells to bone marrow stroma.

L. Bendall, D. Gottlieb, 1999, Leukemia & lymphoma.

HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.

M. Gandhi, J. Seymour, D. Ritchie, 2015, Transplant immunology.

Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma

M. Marangolo, C. Traversari, S. Tanzarella, 2006, British Journal of Cancer.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.

P. Shaw, A. Yong, E. Blyth, 2017, Blood advances.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-speci ﬁ c T cells

P. Shaw, A. Yong, E. Blyth, 2017 .

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation

M. Schwartz, Noam Stern-Ginossar, A. Nachshon, 2021, Frontiers in Cellular and Infection Microbiology.

Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.

A. Foster, K. Bradstock, M. Hertzberg, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Combined chronic myeloid leukaemia and chronic lymphocytic leukaemia in five patients, including one with 17p deletion

D. Gottlieb, L. Dunlop, J. Cooney, 2021, Internal medicine journal.

Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2017, Cytotherapy.

Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A retrospective analysis from The Australasian Bone Marrow Transplant Recipient Registry.

J. Szer, P. Browett, D. Ritchie, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Experiences and unmet needs of family members requested to donate haematopoietic stem cells to an ill relative: findings from a prospective multi-centre study

G. Hill, J. Turner, D. Gottlieb, 2020, Supportive Care in Cancer.

Antifungal T cells--progress in manufacture and prospects for the clinic.

D. Gottlieb, 2015, Cytotherapy.

Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma.

D. Gottlieb, K. Bradstock, K. Micklethwaite, 2007, Cytotherapy.

Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation

K. Bradstock, D. Gottlieb, V. Antonenas, 2007, Bone Marrow Transplantation.

Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation

B. Fazekas de St. Groth, H. McGuire, S. Avdic, 2022, Nature Communications.

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy

Hee‐Je Kim, D. Gottlieb, D. Weisdorf, 2021, Blood cell therapy.

Haploidentical bone marrow transplants for haematological malignancies using non‐myeloablative conditioning therapy and post‐transplant immunosuppression with cyclophosphamide: results from a single Australian centre

I. Kerridge, B. George, M. Hertzberg, 2013, Internal medicine journal.

Motivations, experiences, and perspectives of bone marrow and peripheral blood stem cell donors: thematic synthesis of qualitative studies.

J. Craig, A. Tong, J. Chapman, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.

K. Bradstock, D. Gottlieb, V. Antonenas, 2006, Cytotherapy.

An atypical case of Epstein–Barr virus‐positive plasma cell post‐transplant lymphoproliferative disorder successfully treated with adoptive cell therapy

S. Avdic, A. Bajel, E. Blyth, 2021, British journal of haematology.

Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy

A. Dhingra, T. Schulz, S. Linnenweber-Held, 2020, Frontiers in Cellular and Infection Microbiology.

G. Hill, J. Turner, D. Gottlieb, 2019, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

Pharmacological Management of Severe Neuropathic Pain in a Case of Eosinophilic Meningitis Related to Angiostrongylus cantonensis

J. Bain, D. Gottlieb, W. Schechter, 2018, Case reports in anesthesiology.

Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes

I. Kerridge, B. George, K. Bradstock, 2009, Internal medicine journal.

I. Kerridge, K. Bradstock, M. Hertzberg, 2006, Internal medicine journal.

Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.

K. Bradstock, M. Hertzberg, C. Crombie, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Aryl sulfatase A deficiency in psychiatric and neurologic patients.

G. Bach, D. Gottlieb, M. Kalian, 1987, American journal of medical genetics.

Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.

V. Gebski, K. Bradstock, E. Blyth, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts

S. Saad, L. Bendall, K. Bradstock, 2000, Breast Cancer Research and Treatment.

GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.

L. Bendall, D. Gottlieb, K. Kortlepel, 1995, Leukemia.

The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.

L. Bendall, K. Bradstock, D. Gottlieb, 2001, Experimental hematology.

In vitro generation of influenza-specific polyfunctional CD4+ T cells suitable for adoptive immunotherapy.

E. Blyth, D. Gottlieb, L. Clancy, 2012, Cytotherapy.

The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant Recipients.

I. Kerridge, B. George, P. Ferguson, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A fatal case of acute HHV-6 myocarditis following allogeneic haemopoietic stem cell transplantation.

Y. Brennan, E. Blyth, D. Gottlieb, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans – does it have an abettor role in oxalate, and calcium oxalate crystallization?

J. Fan, U. Herrmann, P. Schwille, 2000, Urological Research.

Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2015, Cytotherapy.

Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy

H. Heslop, A. Meager, M. Brenner, 1989, British journal of haematology.

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

M. Dimopoulos, W. Novotny, P. Marlton, 2021, Blood advances.

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant

B. Gloss, C. Bateman, S. Avdic, 2022, American journal of hematology.

Moving towards pathogen‐specific T cells post‐stem cell transplant as standard of care

E. Blyth, D. Gottlieb, L. Clancy, 2015 .

Adult B-cell acute lymphoblastic leukemia with two unrelated abnormal cytogenetic clones.

A. Smith, S. Prabhu, D. Gottlieb, 2010, Cancer genetics and cytogenetics.

after allogeneic hemopoietic stem cell transplantation lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells Prophylactic infusion of cytomegalovirus-specific cytotoxic T

A. Hansen, K. Bradstock, E. Blyth, 2013 .

Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy

I. Kerridge, B. George, N. Gilroy, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants

I. Kerridge, B. George, N. Gilroy, 2010, Bone Marrow Transplantation.

Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms.

L. Bendall, D. Gottlieb, K. Kortlepel, 1993, Blood.

A Phase 3 Double-Blind Study of the Addition of Tocilizumab versus Placebo to Cyclosporin/Methotrexate GvHD Prophylaxis.

S. Paul, G. Hill, K. Gartlan, 2021, Blood.

Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.

K. Bradstock, D. Gottlieb, K. Bradstock, 1995, Leukemia & lymphoma.

Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis

J. Fan, U. Herrmann, P. Schwille, 1999, Urological Research.

Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity.

F. Luciani, Mandeep Singh, L. Romani, 2020, Blood advances.

Prospects for adoptive T-cell therapy for invasive fungal disease

D. Gottlieb, L. Clancy, Gloria Castellano-González, 2017, Current opinion in infectious diseases.

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

S. Avdic, B. Slobedman, A. Abendroth, 2019, Front. Microbiol..

CMV-specific immune reconstitution following allogeneic stem cell transplantation

E. Blyth, D. Gottlieb, L. Clancy, 2016, Virulence.

A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low‐, intermediate‐, and high‐risk groups: reactivation risk is increased by graft‐versus‐host disease only in the intermediate‐risk group

I. Kerridge, B. George, N. Gilroy, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

Adoptive cell therapies for posttransplant infections.

D. Gottlieb, G. Sutrave, 2019, Current opinion in oncology.

Tumor‐specific but not nonspecific cell‐free circulating DNA can be used to monitor disease response in lymphoma

M. Gandhi, D. Gill, D. Ritchie, 2012, American journal of hematology.

Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic

L. Purins, G. Kennedy, P. Shaw, 2021, Transplantation and cellular therapy.

Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

D. Curtis, G. Kennedy, P. Chiappini, 2020, Blood advances.

Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.

C. Overall, S. Saad, L. Bendall, 2002, Cancer research.

How to diagnose amyloidosis

H. Goodman, P. Mollee, D. Gottlieb, 2014, Internal medicine journal.

New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation

J. Kok, D. Ritchie, W. Rawlinson, 2020, Internal medicine journal.

Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies.

Joey Lai, E. Blyth, D. Gottlieb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stem Cell Biology

D. Marshak, R. Gardner, D. Gottlieb, 2001 .

Immune Cell Profiling Reveals MAIT and Effector Memory CD4+ T Cell Recovery Link to Control of Cytomegalovirus Reactivation after Stem Cell Transplant

H. McGuire, S. Avdic, B. Slobedman, 2021, bioRxiv.

Restriction of Human Cytomegalovirus Infection by Galectin-9

C. Benedict, D. Zajonc, S. Avdic, 2018, Journal of Virology.

Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.

S. Alexander, M. Marangolo, A. Foster, 2004, Blood.

Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.

L. Bendall, D. Gottlieb, A. Daniel, 1994, Experimental hematology.

Identification of novel K562 membrane proteins that adhere to bone marrow fibroblasts.

L. Bendall, D. Gottlieb, K. Bradstock, 1996, Blood.

Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant.

E. Blyth, D. Gottlieb, G. Sutrave, 2017, Cytotherapy.

An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia.

M. Krause, T. Harrington, M. Priglinger, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Malignant plasma cells are sensitive to LAK cell lysis: pre‐clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

H. Heslop, A. Hoffbrand, M. Brenner, 1990, British journal of haematology.

Cellular therapy to treat haematological and other malignancies: progress and pitfalls

P. Fromm, K. Bradstock, D. Hart, 2011, Pathology.

Left atrial strain in cardiac surveillance of bone marrow transplant patients with prior anthracycline exposure.

L. Thomas, D. Gottlieb, M. Altman, 2022, International journal of cardiology.

A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis

I. Kerridge, B. George, K. Bradstock, 2008, Bone Marrow Transplantation.

Human Cytomegalovirus Interleukin-10 Polarizes Monocytes toward a Deactivated M2c Phenotype To Repress Host Immune Responses

S. Avdic, B. Slobedman, A. Abendroth, 2013, Journal of Virology.

Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.

C. Wallington-Beddoe, D. Gottlieb, V. Antonenas, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Variable CD34 1 recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

D. Curtis, G. Kennedy, P. Chiappini, 2020 .

Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.

K. Byth, K. Bradstock, E. Blyth, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre‐ and post‐bone marrow harvest anaemia is associated with lower CD34+ stem cell collection, high harvest volume and female gender

A. Bhattacharyya, E. Blyth, D. Gottlieb, 2020, Internal medicine journal.

The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR

G. Kennedy, A. Spencer, T. Perera, 2022, Bone Marrow Transplantation.

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post‐allogeneic transplant Evans syndrome successfully treated with daratumumab

A. Bhattacharyya, D. Gottlieb, R. Blennerhassett, 2019, British journal of haematology.

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

R. Khanna, A. Cunningham, S. Palmer, 2020, Journal of Virology.

Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

M. Gandhi, D. Gill, D. Ritchie, 2012, Clinical Cancer Research.

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

F. Luciani, B. Gloss, H. McGuire, 2021, Clinical & translational immunology.

Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma

Seung Tae Lee, A. Rapoport, S. Dahiya, 2020, Leukemia & lymphoma.

Treatment with the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrates High Overall Response Rate and Durable Responses in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Updated Results from a Phase 1/2 Trial

W. Novotny, P. Marlton, A. Roberts, 2019, Blood.

The impact of HLA class I and EBV latency‐II antigen‐specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma

M. Roederer, R. Brennan, S. Burrows, 2015, Clinical and experimental immunology.

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.

K. Byth, P. Shaw, E. Blyth, 2013, Blood.

TRANSPLANTATION Donor-derived CMV-speci ﬁ c T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

K. Byth, Peter Shaw, E. Blyth, 2013 .

Predictive Biomarkers and Personalized Medicine SerumCD163 and TARC asDisease Response Biomarkers in Classical Hodgkin Lymphoma

M. Gandhi, D. Gill, D. Ritchie, 2013 .

Predictive Biomarkers and Personalized Medicine SerumCD 163 and TARC asDisease Response Biomarkers in Classical Hodgkin Lymphoma

M. Gandhi, D. Gill, D. Ritchie, 2013 .

Twice Daily Dosing with the Highly Specific BTK Inhibitor, Bgb-3111, Achieves Complete and Continuous BTK Occupancy in Lymph Nodes, and Is Associated with Durable Responses in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

P. Marlton, A. Roberts, S. Opat, 2016 .

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma

Michael L. Wang, P. Marlton, S. Opat, 2017 .

Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD

B. George, L. George, P. Fernández-Peñas, 2012, Bone Marrow Transplantation.

PS1159 POOLED ANALYSIS OF SAFETY DATA FROM MONOTHERAPY STUDIES OF THE BRUTON TYROSINE KINASE (BTK) INHIBITOR, ZANUBRUTINIB (BGB-3111), IN B-CELL MALIGNANCIES

W. Novotny, P. Marlton, A. Roberts, 2019, HemaSphere.

Interim Analysis of Lenalidomide Consolidation on Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)

R. Letestu, M. Béné, S. Mulligan, 2016 .

Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.

E. Leifer, N. Geller, R. Srinivasan, 2002 .

Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins.

L. Bendall, D. Gottlieb, K. Kortlepel, 1993, Leukemia.

Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells.

C. Mason, F. Sedlazeck, F. Luciani, 2021, Blood.

The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma

D. Atanackovic, Seung Tae Lee, A. Rapoport, 2021, British journal of haematology.

Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA‐mismatched allogeneic stem cell transplant using infusion of third‐party T cells from multiple donors in addition to antivirals, rituximab, and surgery

S. Avdic, E. Blyth, D. Gottlieb, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.

P. Shaw, E. Blyth, D. Gottlieb, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy.

J. Romagnoli, M. Marangolo, A. Foster, 2003, Journal of hematotherapy & stem cell research.

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.

A. Hansen, K. Bradstock, E. Blyth, 2008, Blood.

A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.

C. Rooney, M. Marangolo, A. Foster, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.

B. Plachter, A. Cunningham, S. Avdic, 2009, Blood.

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.

Peter Shaw, A. Foster, A. Hansen, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.

A. Dolnikov, T. O'Brien, D. Gottlieb, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib.

W. Novotny, P. Marlton, A. Roberts, 2020 .

Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.

K. Bradstock, M. Hertzberg, C. Crombie, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: three years of follow-up.

W. Novotny, P. Marlton, A. Roberts, 2020, Blood.

Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement

I. Kerridge, P. Shaw, J. Butler, 2020, Internal medicine journal.

Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus.

W. Meyer, E. Blyth, D. Gottlieb, 2012, Cytotherapy.

Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.

L. Bendall, D. Gottlieb, K. Kortlepel, 1997, Experimental hematology.

Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series

A. Bhattacharyya, E. Blyth, D. Gottlieb, 2018, Internal medicine journal.

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: possible evidence of graft‐versus‐tumour effect

H. Gurney, D. Gottlieb, A. Goodwin, 2007, Internal medicine journal.

Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand.

J. Szer, D. Ma, A. Dodds, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey

I. Kerridge, N. Gilroy, J. Moore, 2021, Journal of Cancer Survivorship.

Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia

I. Kerridge, N. Gilroy, J. Moore, 2016, Cancer medicine.

Cytokine manipulation of the immune response in the treatment of human acute leukaemia.

D. Gottlieb, 2002, Current pharmaceutical design.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ming-Yu Liu, Fei Li, D. Blaise, 2023, Heliyon.

Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells.

T. Sorrell, W. Meyer, Balaji Virassamy, 2016, Cytotherapy.

Human cytomegalovirus viral IL-10 polarizes monocytes towards a deactivated M 2 c 1 phenotype to repress host immune

S. Avdic, B. Slobedman, A. Abendroth, 2013 .

Staff influenza vaccination rate in three major blood and marrow transplant units in New South Wales: room for improvement

I. Kerridge, A. Horne, S. Milliken, 2018, Internal medicine journal.

Transient acantholytic dyskeratosis (Grover's disease) after bone marrow transplantation

D. Gottlieb, P. Fernandez Penas, Penny Lim, 2016, The Australasian journal of dermatology.

Reduced Intensity Transplants Using G-CSF-Mobilized Hemopoietic Cells From Haploidentical Related Donors

K. Bradstock, M. Hertzberg, E. Blyth, 2013 .

Human Cytomegalovirus Upregulates Expression of the Lectin Galectin 9 via Induction of Beta Interferon

S. Avdic, B. Slobedman, A. Abendroth, 2014, Journal of Virology.

Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Matched sibling donor-derived piggybac CAR19 T cells induce remission of relapsed/refractory CD19+ malignancy following haematopoietic stem cell transplant

Peter Shaw, G. Mathew, E. Blyth, 2019, Cytotherapy.

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant

Peter Shaw, E. Patrick, H. McGuire, 2022, Blood advances.

Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?

I. Kerridge, N. Gilroy, J. Moore, 2017, Supportive Care in Cancer.

Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden

R. Lock, L. Bendall, K. Bradstock, 2004, Leukemia.

Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2012, Cytotherapy.

Central neurogenic hyperventilation in a patient with medulloblastoma.

I. Steiner, D. Gottlieb, S. Michowitz, 1987, European neurology.